GlassScriptPhysician profile
Andrew C Barlow
NPI 1316949399
$10,696.42
in general payments reported to CMS, 2019-2025
43 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,984 · 2022: $3,129 · 2023: $3,111 · 2024: $1,472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,582.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,382.72 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $1,008.23 | 2021-2024 | Farxiga, Breztri |
| Glaxosmithkline, LLC. | $879.07 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $499.14 | 2021-2024 | Rybelsus, Ozempic |
| Amgen INC. | $461.71 | 2021-2023 | Repatha, Otezla |
| Takeda Pharmaceuticals U.S.A., INC. | $455.53 | 2021-2024 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $448.49 | 2021-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $434.55 | 2021-2023 | Ofev, Jardiance |
| Lundbeck LLC | $423.45 | 2021-2023 | Rexulti, Brintellix |
| Otsuka America Pharmaceutical, INC. | $370.57 | 2021-2024 | Rexulti, Abilify Maintena |
| Lilly USA, LLC | $327.92 | 2021-2023 | Jardiance, Emgality |
| Exact Sciences Corporation | $266.92 | 2023-2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $259.68 | 2021-2024 | Xifaxan, Trulance |
| Pfizer INC. | $224.90 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $214.20 | 2021-2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Barlow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.